Cancer Drug Discovery

Gene Therapy for Cancer (Cancer Drug Discovery and Development)

Gene Therapy for Cancer (Cancer Drug Discovery and Development) by Kelly K. Hunt
English | Feb. 2, 2007 | ISBN: 1588294722 | 483 Pages | PDF | 7.5 MB

The three sections of this volume present currently available cancer gene therapy techniques. Part I describes the various aspects of gene delivery. In Part II, the contributors discuss strategies and targets for the treatment of cancer.
Fluoropyrimidines in Cancer Therapy (Cancer Drug Discovery and Development)

Fluoropyrimidines in Cancer Therapy (Cancer Drug Discovery and Development) by Youcef M. Rustum
English | Dec. 2, 2002 | ISBN: 0896039560 | 340 Pages | PDF | 5 MB

Leading cancer researchers update and review the mechanisms of action and the therapeutic selectivity and efficacy of 5-FU with and without leucovorin and its prodrugs in the treatment of colorectal cancer. Among the combination agents considered are UFT/LV, 5-FU/EU, capecitabine (Xeloda), S-1, and a variety of thymidylate synthase inhibitors.
Hormone Therapy in Breast and Prostate Cancer (Cancer Drug Discovery and Development)

Hormone Therapy in Breast and Prostate Cancer (Cancer Drug Discovery and Development) by JORDAN V. CRAIG
English | Jan. 2, 2002 | ISBN: 0896036731 | 423 Pages | PDF | 5 MB

This book describes the principles underlying targeted hormonal treatments, assesses the actions of new and established agents, and illustrates the new applications of hormonal chemoprevention for breast cancer.
Death Receptors in Cancer Therapy (Cancer Drug Discovery and Development)

Death Receptors in Cancer Therapy (Cancer Drug Discovery and Development) by Wafik S. El-Deiry
English | Dec. 3, 2004 | ISBN: 1588291723 | 387 Pages | PDF | 7 MB

An in depth review of our latest understanding of the molecular events that regulate cell death and those molecules that provide targets for developing agonists or antagonists to modulate death signaling for therapeutic purposes.
Cell Cycle Inhibitors in Cancer Therapy (Cancer Drug Discovery and Development)

Cell Cycle Inhibitors in Cancer Therapy (Cancer Drug Discovery and Development) by Antonio Giordano
English | Nov. 20, 2002 | ISBN: 0896039307 | 327 Pages | PDF | 2.5 MB

Leading clinicians and investigators review in a comprehensible and user-friendly style all the latest information about the molecular biology of cell cycle control and demonstrate its clinical relevance to understanding neoplastic diseases.
Drug Delivery Systems in Cancer Therapy (Cancer Drug Discovery and Development)

Drug Delivery Systems in Cancer Therapy (Cancer Drug Discovery and Development) by Dennis M. Brown
English | Sep. 8, 2003 | ISBN: 0896038882 | 402 Pages | PDF | 2.5 MB

Leading experts survey the currently available technologies designed to improve the delivery of today's cancer chemotherapeutic agents.
EGFR Signaling Networks in Cancer Therapy (Cancer Drug Discovery and Development) 2009th Edition

EGFR Signaling Networks in Cancer Therapy (Cancer Drug Discovery and Development) by John D. Haley
English | Sep. 25, 2008 | ISBN: 1588299481 | 390 Pages | PDF | 4,5 MB

The epidermal gro wth factor (EGF ) receptor and its downstream signal transduction networks have been implicated in the ontology and maintenance of tumor tissues, which has motivated the discovery and development of molecularly targeted anti-EGF receptor therapies.
Camptothecins in Cancer Therapy (Cancer Drug Discovery and Development) 2005th Edition

Camptothecins in Cancer Therapy (Cancer Drug Discovery and Development) by Val R. Adams
English | Feb. 1, 2005 | ISBN: 1588290271 | 474 Pages | PDF | 7 MB

A critical review our current understanding of camptothecins, their shortcomings, and of the possibilities for improving their clinical performance. The authors discuss new camptothecin analog development, drug delivery issues for optimizing their anticancer activity, and their potential use in a variety of different cancers.
Antiangiogenic Agents in Cancer Therapy (Cancer Drug Discovery and Development) by Beverly A. Teicher

Antiangiogenic Agents in Cancer Therapy (Cancer Drug Discovery and Development) by Beverly A. Teicher
English | Dec 28, 1998 | ISBN: 0896036413 | 462 Pages | PDF | 12 MB

Beverly Teicher and a panel of distinguished investigators survey the state-of-the-art of antiangiogenesis research from the lab bench to clinical trials.
Antiangiogenic Agents in Cancer Therapy (Cancer Drug Discovery and Development) by Lee M. Ellis

Antiangiogenic Agents in Cancer Therapy (Cancer Drug Discovery and Development) by Lee M. Ellis
English | Dec 12, 2007 | ISBN: 1588298701 | 556 Pages | PDF | 15 MB

This volume represents a compendium of scientific findings and approaches to the study of angiogenesis in cancer. The second edition of Antiangiogenic Agents in Cancer Therapy is intended to give a current perspective on the state-of-the-art of angiogenensis and therapy directed at this process.